Cargando…
Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain
STUDY DESIGN. A 14-week, randomized, double-blind, multicenter, placebo-controlled study of Japanese patients with chronic low back pain (CLBP) who were randomized to either duloxetine 60 mg once daily or placebo. OBJECTIVE. This study aimed to assess the efficacy and safety of duloxetine monotherap...
Autores principales: | Konno, Shinichi, Oda, Natsuko, Ochiai, Toshimitsu, Alev, Levent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113250/ https://www.ncbi.nlm.nih.gov/pubmed/27831985 http://dx.doi.org/10.1097/BRS.0000000000001707 |
Ejemplares similares
-
A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
por: Uchio, Yuji, et al.
Publicado: (2018) -
A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
por: Murakami, Masato, et al.
Publicado: (2015) -
Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study
por: Tsuji, Toshinaga, et al.
Publicado: (2017) -
Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
por: Alev, Levent, et al.
Publicado: (2017) -
Antibiotics versus placebo in adults with CT-confirmed uncomplicated acute appendicitis (APPAC III): randomized double-blind superiority trial
por: Salminen, Paulina, et al.
Publicado: (2022)